{"id":"W4311940830","doi":"10.1093/rheumatology/keac689","title":"Efficacy of subcutaneous <i>vs</i> intravenous infliximab in rheumatoid arthritis: a post-hoc analysis of a randomized phase III trial","year":2022,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Medac; Celltrion Healthcare; Biogen; Celltrion; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Rheumatoid arthritis; Post-hoc analysis; Infliximab; Internal medicine; Randomized controlled trial; Clinical endpoint; Post hoc; Surgery; Physical therapy; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01795629,0.002238083,0.005571351,0.0004429815,0.00042354,0.001722262,0.001221762,0.001426828,0.004820673],"category_scores_gemma":[0.01253301,0.0006446827,0.007434697,0.0004798239,0.001433226,0.001335701,0.0007373046,0.003552992,0.0007511452],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001267916,"about_ca_system_score_gemma":0.001670606,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004599458,"about_ca_topic_score_gemma":0.0006744749,"domain_scores_codex":[0.987664,0.009410182,0.0006513381,0.001034654,0.0004764819,0.0007632938],"domain_scores_gemma":[0.9813565,0.01157574,0.003210571,0.001914679,0.0008379992,0.001104453],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.988142,0.001323009,0.0005821156,0.0002275039,0.004387507,0.00002284465,0.00002755188,0.0005238133,0.000994794,0.0000585869,0.0003236953,0.003386479],"study_design_scores_gemma":[0.6979932,0.2686639,0.009776632,0.00009729419,0.0127177,0.00007315553,0.00006775654,0.005363571,0.00341828,0.0005287974,0.001228266,0.00007135874],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9861208,0.002402502,0.002853688,0.0005598591,0.0007442109,0.003982506,0.001420106,0.0001730828,0.001743201],"genre_scores_gemma":[0.9873329,0.0006875332,0.002931035,0.0006282764,0.0004497297,0.004657529,0.001318369,0.00009008613,0.001904624],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01795629,"threshold_uncertainty_score":0.09496313,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00965550448142467,"score_gpt":0.2743830761480294,"score_spread":0.2647275716666048,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}